Objective: to study the application effect of nitrocellulose vaginal soft capsule (blue) in the clinical treatment of vaginitis. Methods: select our hospital during May 2020 to April 202160 vaginitis patients, even pa...Objective: to study the application effect of nitrocellulose vaginal soft capsule (blue) in the clinical treatment of vaginitis. Methods: select our hospital during May 2020 to April 202160 vaginitis patients, even patients, observation and control group 30 cases, control group using conventional treatment plan, observation group auxiliary treatment, compare the two groups of patients treatment efficiency, recurrence rate and incidence of adverse reactions, analyze the treatment cycle and patient satisfaction score. Results: the total treatment efficiency of the observation group was 96.67% (29 / 30), The total treatment efficiency of the control group was 70.00% (21 / 30), Data vary between groups, Statistical significance;The recurrence rate of vaginitis in the observation group was 3.33% (1 in 30), The control group's recurrence rate was 26.67% (8 / 30), Statistical significance (P <0.05);Two cases had heartburn, itching and one case who had nausea in the observation group;The control group had 4 cases of external heartburn, itching and 4 cases of nausea, There were 3 cases of dizziness, The incidence of adverse reactions in the observed group was 10.00% lower than 36.67% in the control group, Comparison between groups were obvious, Statistically significant (P <0.05).Treatment cycle (20.41 ± 2.28) d, satisfaction score (94.35 ± 2.08), treatment cycle (22.23 ± 3.12) d, satisfaction score (93.42 ± 1.150), P <0.05 after data comparison. Conclusion: in the clinical treatment of vaginitis, the use of nitrofurthil ycin is very effective, which can improve the overall efficiency of treatment and control the incidence of disease recurrence and adverse reactions. Relevant treatment methods are also conducive to shortening the rehabilitation treatment cycle and improving the patient satisfaction score, which is of great significance to accelerate the treatment process of patients, and can be promoted.展开更多
Objective: to analyze the positive rate of cervical cancer by TCT and HPV in cervical cancer screening, so as to improve the clinical screening ability of cervical cancer and provide the basis for cervical cancer scre...Objective: to analyze the positive rate of cervical cancer by TCT and HPV in cervical cancer screening, so as to improve the clinical screening ability of cervical cancer and provide the basis for cervical cancer screening in the future. Methods: 3902 women in womens health examination in our department were selected as the research objects. In the physical examination, each research object underwent HPV test and TCT test, and then the results of TCT test, HPV test and TCT combined with HPV test were compared one by one. The diagnostic gold standard was biopsy results. Results: among the 3902 cervical cancer screeners, there were 1575 cases with CIN and 2327 cases with chronic inflammation by histopathological examination. TCT was positive in 1864 cases and negative in 2038 cases, with sensitivity of 59.68%, false negative rate of 40.32%, specificity of 60.29%, false positive rate of 39.71% and correct index of 0.1997. There were 3245 positive HPV cases and 657 negative HPV cases, with sensitivity of 83.81%, false negative rate of 16.19%, specificity of 17.27%, and false positive rate of 82.72% and correct index of 0.0108. TCT+HPV was positive in 1503 cases and negative in 2399 cases, with sensitivity of 94.22%, false negative rate of 5.78%, specificity of 99.18%, false positive rate of 0.82% and correct index of 0.934. Conclusion: single HPV test and TCT test in patients with cervical cancer have high sensitivity and specificity, while TCT+HPV test has the highest sensitivity, specificity and correctness. It is helpful to improve the diagnosis rate of cervical cancer by combining the two test methods clinically.展开更多
文摘Objective: to study the application effect of nitrocellulose vaginal soft capsule (blue) in the clinical treatment of vaginitis. Methods: select our hospital during May 2020 to April 202160 vaginitis patients, even patients, observation and control group 30 cases, control group using conventional treatment plan, observation group auxiliary treatment, compare the two groups of patients treatment efficiency, recurrence rate and incidence of adverse reactions, analyze the treatment cycle and patient satisfaction score. Results: the total treatment efficiency of the observation group was 96.67% (29 / 30), The total treatment efficiency of the control group was 70.00% (21 / 30), Data vary between groups, Statistical significance;The recurrence rate of vaginitis in the observation group was 3.33% (1 in 30), The control group's recurrence rate was 26.67% (8 / 30), Statistical significance (P <0.05);Two cases had heartburn, itching and one case who had nausea in the observation group;The control group had 4 cases of external heartburn, itching and 4 cases of nausea, There were 3 cases of dizziness, The incidence of adverse reactions in the observed group was 10.00% lower than 36.67% in the control group, Comparison between groups were obvious, Statistically significant (P <0.05).Treatment cycle (20.41 ± 2.28) d, satisfaction score (94.35 ± 2.08), treatment cycle (22.23 ± 3.12) d, satisfaction score (93.42 ± 1.150), P <0.05 after data comparison. Conclusion: in the clinical treatment of vaginitis, the use of nitrofurthil ycin is very effective, which can improve the overall efficiency of treatment and control the incidence of disease recurrence and adverse reactions. Relevant treatment methods are also conducive to shortening the rehabilitation treatment cycle and improving the patient satisfaction score, which is of great significance to accelerate the treatment process of patients, and can be promoted.
文摘Objective: to analyze the positive rate of cervical cancer by TCT and HPV in cervical cancer screening, so as to improve the clinical screening ability of cervical cancer and provide the basis for cervical cancer screening in the future. Methods: 3902 women in womens health examination in our department were selected as the research objects. In the physical examination, each research object underwent HPV test and TCT test, and then the results of TCT test, HPV test and TCT combined with HPV test were compared one by one. The diagnostic gold standard was biopsy results. Results: among the 3902 cervical cancer screeners, there were 1575 cases with CIN and 2327 cases with chronic inflammation by histopathological examination. TCT was positive in 1864 cases and negative in 2038 cases, with sensitivity of 59.68%, false negative rate of 40.32%, specificity of 60.29%, false positive rate of 39.71% and correct index of 0.1997. There were 3245 positive HPV cases and 657 negative HPV cases, with sensitivity of 83.81%, false negative rate of 16.19%, specificity of 17.27%, and false positive rate of 82.72% and correct index of 0.0108. TCT+HPV was positive in 1503 cases and negative in 2399 cases, with sensitivity of 94.22%, false negative rate of 5.78%, specificity of 99.18%, false positive rate of 0.82% and correct index of 0.934. Conclusion: single HPV test and TCT test in patients with cervical cancer have high sensitivity and specificity, while TCT+HPV test has the highest sensitivity, specificity and correctness. It is helpful to improve the diagnosis rate of cervical cancer by combining the two test methods clinically.
